Corticotropin Solution
NDC Package 83236-100-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Corticotropin solution is a medication used to treat a certain type of seizure in children (infantile spasms). This formulation utilizes a solution delivery system. Marketed by Mallinckrodt Pharmaceuticals Ireland Limited, this product is identified by NDC 83236-100.

Identification & Billing

NDC Package Code
83236-100-01
Package Description
23.1 kg in 1 CAN
Product Code
83236-100
11-Digit Billing Format
83236010001

Clinical Specifications

Proprietary Name
Corticotropin
Non-Proprietary Name
Corticotropin
Substance Name
Corticotropin
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Active Ingredient(s)
CORTICOTROPIN 638 [USP'U]/.001kg
Usage Information
This medication is used to treat a certain type of seizure in children (infantile spasms). This medication is also used to treat conditions such as multiple sclerosis, arthritis, lupus, eye conditions, skin/kidney/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. Corticotropin is a hormone.

Regulatory & Marketing

Labeler Name
Mallinckrodt Pharmaceuticals Ireland Limited
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
08-17-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83236-100-01 identifies a specific commercial package of 23.1 kg in 1 can of Corticotropin (UNFINISHED drug), drug for further processing labeled by Mallinckrodt Pharmaceuticals Ireland Limited. This solution is formulated for use and contains corticotropin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mallinckrodt Pharmaceuticals Ireland Limited on August 17, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a certain type of seizure in children (infantile spasms). This medication is also used to treat conditions such as multiple sclerosis, arthritis, lupus, eye conditions, skin/kidney/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. Corticotropin is a hormone.

How is this Mallinckrodt Pharmaceuticals Ireland Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83236010001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83236-100-01
11-Digit CMS (5-4-2)
83236-0100-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.